155 related articles for article (PubMed ID: 14993643)
1. A single RNA recognition motif in splicing factor ASF/SF2 directs it to nuclear sites of adenovirus transcription.
Lindberg A; Gama-Carvalho M; Carmo-Fonseca M; Kreivi JP
J Gen Virol; 2004 Mar; 85(Pt 3):603-608. PubMed ID: 14993643
[TBL] [Abstract][Full Text] [Related]
2. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
Dauksaite V; Akusjärvi G
Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.
Molin M; Akusjärvi G
J Virol; 2000 Oct; 74(19):9002-9. PubMed ID: 10982344
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
[TBL] [Abstract][Full Text] [Related]
5. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
Shih SR; Krug RM
EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
Wang J; Xiao SH; Manley JL
Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
[TBL] [Abstract][Full Text] [Related]
8. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
[TBL] [Abstract][Full Text] [Related]
9. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
[TBL] [Abstract][Full Text] [Related]
10. A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding.
Cao W; Garcia-Blanco MA
J Biol Chem; 1998 Aug; 273(32):20629-35. PubMed ID: 9685421
[TBL] [Abstract][Full Text] [Related]
11. The Drosophila RNA-binding protein RBP1 is localized to transcriptionally active sites of chromosomes and shows a functional similarity to human splicing factor ASF/SF2.
Kim YJ; Zuo P; Manley JL; Baker BS
Genes Dev; 1992 Dec; 6(12B):2569-79. PubMed ID: 1340470
[TBL] [Abstract][Full Text] [Related]
12. Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.
Somberg M; Schwartz S
J Virol; 2010 Aug; 84(16):8219-30. PubMed ID: 20519389
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
[TBL] [Abstract][Full Text] [Related]
14. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
Dauksaite V; Akusjärvi G
J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
[TBL] [Abstract][Full Text] [Related]
15. SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells.
McPhillips MG; Veerapraditsin T; Cumming SA; Karali D; Milligan SG; Boner W; Morgan IM; Graham SV
J Virol; 2004 Oct; 78(19):10598-605. PubMed ID: 15367627
[TBL] [Abstract][Full Text] [Related]
16. Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity.
Cáceres JF; Misteli T; Screaton GR; Spector DL; Krainer AR
J Cell Biol; 1997 Jul; 138(2):225-38. PubMed ID: 9230067
[TBL] [Abstract][Full Text] [Related]
17. Pre-mRNA splicing in the absence of an SR protein RS domain.
Zhu J; Krainer AR
Genes Dev; 2000 Dec; 14(24):3166-78. PubMed ID: 11124808
[TBL] [Abstract][Full Text] [Related]
18. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
Liu X; Mayeda A; Tao M; Zheng ZM
J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
[TBL] [Abstract][Full Text] [Related]
19. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
Cao W; Jamison SF; Garcia-Blanco MA
RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
[TBL] [Abstract][Full Text] [Related]
20. Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2/ASF.
Sanford JR; Coutinho P; Hackett JA; Wang X; Ranahan W; Caceres JF
PLoS One; 2008 Oct; 3(10):e3369. PubMed ID: 18841201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
